OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS
Avobenzone 3%
Oxybenzone 3%
Octylmethoxycinnamate 7.5%
ACTIVE INGREDIENTS
Avobenzone 3%
Oxybenzone 3%
Octylmethoxycinnamate 7.5%
DIRECTIONS
Apply liberally and evenly 15 minutes before sun exposure
Children under 6 months of age: Ask a doctor
Apply to all skin exposed to the sun
Reapply at least every 2 hours
Use a water resistant sunscreen if swimming or sweating
WARNINGS
For external use only. Do not use on broken or damaged skin.
Skin Cancer/Skin Ageing Alert: Spending time in the sun increases your risk of skin cancer and early skin ageing. This product has been shown only to help prevent sunburn, not skin cancer or early skin ageing.
Keep out of reach of children.
Keep out of reach of children. If product is swalowed, get medical help or contact a Poison Control Center right away.
When using this product, keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if any rush occurs.
INACTIVE INGREDIENTS
Water
Ethylhexyl palmitate
Caprylic triglyceride
Capric triglyceride
Polyacrylamide
c13-14 Isoparaffin
Laureth-7
Polysorbate 60
Cetearyl alcohol
Glycerin
Cyclopentasiloxane
Clyclotetrasiloxane
dimethiconol
Caprylhydroxamic acid
phenoxyethanol
methylpropanediol
tocopheryl acetate (vitamin e)
lanolin (medical grade)
Sorbitan stearate
Hydrolyzed (Marine) collagen
Tetrasodium EDTA
Actinidia chinensis (kiwi) fruit extract
Leptospermum scoparium Mel UMF 15+ Active Manuka Honey
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43617-3415-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c79a-f6ea-e053-dbdaa90aa703 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43617-3415-1 | LANOCREME HYDRATING DAY SPF15 | 1 in 1 BOX | CREAM | 1 | 5 | |
| 43617-3415-1 | LANOCREME HYDRATING DAY SPF15 | 50 g in 1 JAR | CREAM | 50 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43617-3415 | LANOCREME HYDRATING DAY SPF15 (AVOBENZONE, OXYBENZONE, OCTYL METHOXYCINNAMATE) CREAM [LANOCORP PACIFIC LTD] | 5 | Legacy NDC, 2 package rows | 20120514_7e37ab2d-00ea-49bb-acc7-cb4c9a3281a1.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 5 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 5 | |
| OXYBENZONE | ACTIVE INGREDIENT | 95OOS7VE0Y | 5 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 5 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 5 | |
| OXYBENZONE | ACTIVE MOIETY | 95OOS7VE0Y | 5 | |
| ALPHA-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 5 | |
| C13-14 Isoparaffin | INACTIVE INGREDIENT | E4F12ROE70 | 5 | |
| Caprylhydroxamic acid | INACTIVE INGREDIENT | UPY805K99W | 5 | |
| Cetostearyl Alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 5 | |
| Cyclomethicone 4 | INACTIVE INGREDIENT | CZ227117JE | 5 | |
| Cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 5 | |
| Dimethiconol (41 MPA.S) | INACTIVE INGREDIENT | 343C7U75XW | 5 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 5 | |
| Ethylhexyl palmitate | INACTIVE INGREDIENT | 2865993309 | 5 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 5 | |
| HONEY | INACTIVE INGREDIENT | Y9H1V576FH | 5 | |
| HYDROLYSED MARINE COLLAGEN (ENZYMATIC; 2000 MW) | INACTIVE INGREDIENT | 2WID9OCG7P | 5 | |
| KIWI FRUIT | INACTIVE INGREDIENT | 71ES77LGJC | 5 | |
| Lanolin | INACTIVE INGREDIENT | 7EV65EAW6H | 5 | |
| Laureth-7 | INACTIVE INGREDIENT | Z95S6G8201 | 5 | |
| Methylpropanediol | INACTIVE INGREDIENT | N8F53B3R4R | 5 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 5 | |
| Polysorbate 60 | INACTIVE INGREDIENT | CAL22UVI4M | 5 | |
| SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER (1:1; 90000-150000 MPA.S) | INACTIVE INGREDIENT | 5F4963KLHS | 5 | |
| Sorbitan monostearate | INACTIVE INGREDIENT | NVZ4I0H58X | 5 | |
| Tricaprin | INACTIVE INGREDIENT | O1PB8EU98M | 5 | |
| Tricaprylin | INACTIVE INGREDIENT | 6P92858988 | 5 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43617-3415 | 43617-3415-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | SPRAY / NASAL | NA | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SHAMPOO / TOPICAL | 1.33 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | EMULSION / ORAL | 20 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / RECTAL | 105 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | AEROSOL, FOAM / TOPICAL | 30 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | LOTION / TOPICAL | 89 mg | ||
| Sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SOLUTION / TOPICAL | NA | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | EMULSION / OPHTHALMIC | 0.02 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | INJECTION / INTRAVENOUS | 0.01 %w/v | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SPONGE / TOPICAL | 0.14 %w/w | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | CREAM / TOPICAL | 225 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Lanolin | LANOLIN | 7EV65EAW6H | LOTION / TOPICAL | 1.5 %w/w | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUSPENSION / ORAL | 125 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | LOTION / TOPICAL | 0.17 %w/w | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / VAGINAL | 6 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | TABLET / ORAL | 5 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / OPHTHALMIC | 3 %w/w | ||
| Sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | AEROSOL, FOAM / TOPICAL | 0.55 %w/w | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Tricaprylin | TRICAPRILIN | 6P92858988 | INJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL | 1 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | OINTMENT / TOPICAL | 2 %w/w | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | GUM, CHEWING / BUCCAL | 5 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUSPENSION / TOPICAL | 2.85 %w/w | ||
| Sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | OINTMENT / TOPICAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 30c41d95-0796-4904-98b2-36655e8b6fbc | 7e37ab2d-00ea-49bb-acc7-cb4c9a3281a1 | 2012-04-27 | Warnings | 30c41d95-0796-4904-98b2-36655e8b6fbc 7e37ab2d-00ea-49bb-acc7-cb4c9a3281a1 |
Adverse event summaries are temporarily unavailable. Other product information remains available.